These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6223754)

  • 41. Cyclosporin. Mechanism of action: in vitro studies.
    Hess AD; Colombani PM
    Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
    [No Abstract]   [Full Text] [Related]  

  • 42. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.
    Bucy RP
    Immunopharmacology; 1988; 15(2):65-72. PubMed ID: 2967266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
    Hess AD; Tutschka PJ
    J Immunol; 1980 Jun; 124(6):2601-8. PubMed ID: 6445383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
    Granelli-Piperno A; Keane M; Steinman RM
    Transplantation; 1988 Aug; 46(2 Suppl):53S-60S. PubMed ID: 3136567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct effect of cyclosporin A on CD8+ T lymphocytes in a primary mixed lymphocyte reaction.
    Kiziroglu F; Miller RG
    Immunol Lett; 1990 May; 24(2):77-86. PubMed ID: 2141324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
    Hardt C; Diamantstein T; Wagner H
    Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
    Granelli-Piperno A; Inaba K; Steinman RM
    J Exp Med; 1984 Dec; 160(6):1792-802. PubMed ID: 6334715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro.
    Furukawa Y; Matsumori A; Hirozane T; Matsui S; Sato Y; Ono K; Sasayama S
    Clin Immunol Immunopathol; 1996 Apr; 79(1):25-35. PubMed ID: 8612348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
    Muul LM; Gately MK
    J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cyclosporin and interleukin-2 on the restoration of in vitro immune responses to cytomegalovirus.
    Converse PJ; Hess AD
    Scand J Immunol; 1985 Feb; 21(2):109-18. PubMed ID: 2983414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of cytotoxic T lymphocyte activation by L-ornithine.
    Dröge W; Männel D; Falk W; Lehmann V; Schmidt H; Nick S; Häcker-Shahin B; Jänicke R
    J Immunol; 1985 May; 134(5):3379-83. PubMed ID: 3920317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Wallace RE; Durr FE
    Int J Immunopharmacol; 1984; 6(5):475-82. PubMed ID: 6334042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction.
    Ming JE; Steinman RM; Granelli-Piperno A
    Clin Exp Immunol; 1992 Jul; 89(1):148-53. PubMed ID: 1385765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenically activated helper T cells are required as stimulator cells for optimal activation of cytotoxic T lymphocytes under conditions of limiting helper factors.
    Moyers C; Droege W
    Cell Immunol; 1983 Jan; 75(1):1-12. PubMed ID: 6218891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.